Prenatal Exposure to Nonpersistent Environmental Chemicals and Postpartum Depression.
Journal
JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550
Informations de publication
Date de publication:
20 Sep 2023
20 Sep 2023
Historique:
pmc-release:
20
09
2024
medline:
20
9
2023
pubmed:
20
9
2023
entrez:
20
9
2023
Statut:
aheadofprint
Résumé
Postpartum depression (PPD) affects up to 20% of childbearing individuals, and a significant limitation in reducing its morbidity is the difficulty in modifying established risk factors. Exposure to synthetic environmental chemicals found in plastics and personal care products, such as phenols, phthalates, and parabens, are potentially modifiable and plausibly linked to PPD and have yet to be explored. To evaluate associations of prenatal exposure to phenols, phthalates, parabens, and triclocarban with PPD symptoms. This was a prospective cohort study from 5 US sites, conducted from 2006 to 2020, and included pooled data from 5 US birth cohorts from the National Institutes of Health Environmental Influences on Child Health Outcomes (ECHO) consortium. Participants were pregnant individuals with data on urinary chemical concentrations (phenols, phthalate metabolites, parabens, or triclocarban) from at least 1 time point in pregnancy and self-reported postnatal depression screening assessment collected between 2 weeks and 12 months after delivery. Data were analyzed from February to May 2022. Phenols (bisphenols and triclosan), phthalate metabolites, parabens, and triclocarban measured in prenatal urine samples. Depression symptom scores were assessed using the Edinburgh Postnatal Depression Scale (EPDS) or the Center for Epidemiologic Studies Depression Scale (CES-D), harmonized to the Patient-Reported Measurement Information System (PROMIS) Depression scale. Measures of dichotomous PPD were created using both sensitive (EPDS scores ≥10 and CES-D scores ≥16) and specific (EPDS scores ≥13 and CES-D scores ≥20) definitions. Among the 2174 pregnant individuals eligible for analysis, nearly all (>99%) had detectable levels of several phthalate metabolites and parabens. PPD was assessed a mean (SD) of 3 (2.5) months after delivery, with 349 individuals (16.1%) and 170 individuals (7.8%) screening positive for PPD using the sensitive and specific definitions, respectively. Linear regression results of continuous PROMIS depression T scores showed no statistically significant associations with any chemical exposures. Models examining LMW and HMW phthalates and di (2-ethylhexyl) phthalate had estimates in the positive direction whereas all others were negative. A 1-unit increase in log-transformed LMW phthalates was associated with a 0.26-unit increase in the PROMIS depression T score (95% CI, -0.01 to 0.53; P = .06). This corresponded to an odds ratio (OR) of 1.08 (95% CI, 0.98-1.19) when modeling PPD as a dichotomous outcome and using the sensitive PPD definition. HMW phthalates were associated with increased odds of PPD (OR, 1.11; 95% CI, 1.00-1.23 and OR, 1.10; 95% CI, 0.96-1.27) for the sensitive and specific PPD definitions, respectively. Sensitivity analyses produced stronger results. Phthalates, ubiquitous chemicals in the environment, may be associated with PPD and could serve as important modifiable targets for preventive interventions. Future studies are needed to confirm these observations.
Identifiants
pubmed: 37728908
pii: 2809718
doi: 10.1001/jamapsychiatry.2023.3542
pmc: PMC10512164
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES017885
Pays : United States
Organisme : NIH HHS
ID : UG3 OD023271
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023271
Pays : United States
Investigateurs
P B Smith
(PB)
K L Newby
(KL)
Lisa P Jacobson
(LP)
C B Parker
(CB)
Richard C Gershon
(RC)
David Cella
(D)
Catherine Karr
(C)
Alex Mason
(A)
Frances Tylavsky
(F)
Jean Kerver
(J)
Charles J Barone
(CJ)
Nigel Paneth
(N)
Akram N Alshawabkeh
(AN)
Sheela Sathyanarayana
(S)
Dana Dabelea
(D)
Jose Cordero
(J)
Kaja Z LeWinn
(KZ)
Chris Fussman
(C)
Références
Psychol Med. 2017 Apr;47(5):787-799
pubmed: 27866476
Biol Sex Differ. 2021 Jan 6;12(1):6
pubmed: 33407895
Environ Int. 2020 Jan;134:105304
pubmed: 31726358
Environ Sci Technol. 2021 Aug 17;55(16):11155-11165
pubmed: 34347462
J Endocrinol. 2007 Sep;194(3):603-9
pubmed: 17761899
Environ Health Perspect. 2011 Jul;119(7):914-20
pubmed: 21450549
Infant Behav Dev. 2010 Feb;33(1):1-6
pubmed: 19962196
Womens Health (Lond). 2019 Jan-Dec;15:1745506519844044
pubmed: 31035856
Environ Health. 2015 Jan 26;14:9
pubmed: 25619201
J Affect Disord Rep. 2022 Jul;9:
pubmed: 35966253
JAMA Psychiatry. 2018 Mar 1;75(3):247-253
pubmed: 29387878
Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):49-60
pubmed: 24063973
J Fam Pract. 2001 Feb;50(2):117-22
pubmed: 11219558
Curr Opin Pediatr. 2018 Apr;30(2):260-262
pubmed: 29356702
Neurotoxicology. 2020 Jan;76:183-190
pubmed: 31730893
Acta Psychiatr Scand. 2009 May;119(5):350-64
pubmed: 19298573
Int J Androl. 2006 Feb;29(1):134-9; discussion 181-5
pubmed: 16466533
J Clin Epidemiol. 2016 May;73:89-102
pubmed: 26952842
Pediatr Res. 2022 Nov;92(5):1215-1216
pubmed: 34131291
Brain Res Bull. 2005 Apr 15;65(3):255-60
pubmed: 15811589
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9956-61
pubmed: 23716699
BMJ Open. 2022 Oct 21;12(10):e064288
pubmed: 36270755
Environ Health. 2013 Sep 13;12(1):80
pubmed: 24034517
Heredity (Edinb). 2005 Sep;95(3):221-7
pubmed: 16077740
Epidemiology. 2009 Jul;20(4):488-95
pubmed: 19525685
BMJ. 2020 Nov 11;371:m4022
pubmed: 33177069
J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):204-15
pubmed: 21899826
J Endocr Soc. 2019 Apr 11;3(6):1127-1149
pubmed: 31093596
Clin Obstet Gynecol. 2018 Sep;61(3):591-603
pubmed: 29596076
Curr Opin Behav Sci. 2016 Feb;7:69-75
pubmed: 27019862
PLoS One. 2016 May 16;11(5):e0155431
pubmed: 27182821
Compr Physiol. 2016 Jun 13;6(3):1135-60
pubmed: 27347888
Annu Rev Clin Psychol. 2013;9:379-407
pubmed: 23394227
Endocr Rev. 2015 Dec;36(6):E1-E150
pubmed: 26544531
Am J Obstet Gynecol. 2009 Apr;200(4):357-64
pubmed: 19318144
J Am Acad Child Adolesc Psychiatry. 2011 May;50(5):460-70
pubmed: 21515195
Reprod Biol Endocrinol. 2015 Jan 17;13:4
pubmed: 25596636
Psychol Assess. 2014 Jun;26(2):513-27
pubmed: 24548149
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
J Clin Psychol. 2009 Dec;65(12):1258-69
pubmed: 19827112
Endocr Rev. 2012 Jun;33(3):378-455
pubmed: 22419778
Environ Health Perspect. 2011 Mar;119(3):409-15
pubmed: 21362588
Int J Hyg Environ Health. 2021 Jul;236:113798
pubmed: 34186503
Environ Int. 2021 Nov;156:106656
pubmed: 34062395
CNS Spectr. 2015 Feb;20(1):48-59
pubmed: 25263255
Am Ind Hyg Assoc J. 1993 Oct;54(10):615-27
pubmed: 8237794
Psychol Med. 2018 May;48(7):1190-1200
pubmed: 28950923
J Clin Endocrinol Metab. 2021 Jun 16;106(7):1887-1899
pubmed: 33792735
Environ Health Perspect. 2020 Oct;128(10):107001
pubmed: 33026246
Curr Probl Pediatr Adolesc Health Care. 2008 Feb;38(2):34-49
pubmed: 18237855
Biochem Pharmacol. 2022 Jan;195:114835
pubmed: 34774531
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Environ Sci Technol. 2013 Apr 2;47(7):3439-47
pubmed: 23469879
Psychol Assess. 2021 Jul;33(7):610-618
pubmed: 34060864
Dev Psychopathol. 2020 Dec;32(5):1625-1639
pubmed: 33427164
Lancet Psychiatry. 2015 Jan;2(1):59-67
pubmed: 26359613
Environ Int. 2020 Jun;139:105694
pubmed: 32259757
Environ Res. 2008 Feb;106(2):257-69
pubmed: 17976571
Environ Health Perspect. 2002 Jun;110 Suppl 3:415-22
pubmed: 12060838
Obstet Gynecol. 2005 Nov;106(5 Pt 1):1071-83
pubmed: 16260528
Environ Health Perspect. 2011 Jun;119(6):878-85
pubmed: 21233055
Environ Health Perspect. 2016 Oct;124(10):1600-1607
pubmed: 26947464